NORBATRIN

This brand name is authorized in Nigeria.

Active ingredients

The drug NORBATRIN contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Neomycin UNII `I16QD7X297` - NEOMYCIN
	Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.
	Read more about Neomycin
`2`	Bacitracin UNII `89Y4M234ES` - BACITRACIN ZINC
	Read more about Bacitracin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07AA51	Neomycin, combinations	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics
Discover more medicines within A07AA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100745
Switch country to Nigeria in order to find specific presentations of NORBATRIN

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.